top of page
A L T I T U D E
Life Science Ventures
Companies in the News
EBR Systems, Inc. Announces US Food and Drug Administration Approval of EBR's WiSE CRT System
EBR Systems, Inc. announced the US Food and Drug Administration (FDA) approval of EBR's WiSE cardiac resynchronisation therapy ("CRT")...
Apr 15
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with relapsed and/or...
Apr 15
bottom of page